Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5144261012 | Vedolizumab 300 mg powder for solution for infusion and/or injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5144262017 | Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vedolizumab 300 mg powder for solution for infusion and/or injection vial | Is a | Product containing only vedolizumab in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Vedolizumab 300 mg powder for solution for infusion and/or injection vial | Has manufactured dose form | Powder for conventional release solution for infusion and/or injection (dose form) | true | Inferred relationship | Some | ||
| Vedolizumab 300 mg powder for solution for infusion and/or injection vial | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
| Vedolizumab 300 mg powder for solution for infusion and/or injection vial | Has precise active ingredient | Vedolizumab | true | Inferred relationship | Some | 1 | |
| Vedolizumab 300 mg powder for solution for infusion and/or injection vial | Has basis of strength substance (attribute) | Vedolizumab | true | Inferred relationship | Some | 1 | |
| Vedolizumab 300 mg powder for solution for infusion and/or injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Vedolizumab 300 mg powder for solution for infusion and/or injection vial | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Vedolizumab 300 mg powder for solution for infusion vial | Is a | True | Vedolizumab 300 mg powder for solution for infusion and/or injection vial | Inferred relationship | Some | |
| Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | True | Vedolizumab 300 mg powder for solution for infusion and/or injection vial | Inferred relationship | Some |
Reference Sets
FHIR